Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MYGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 95.60M
March 31, 2026 94.40M
December 31, 2025 93.50M
September 30, 2025 93.10M
June 30, 2025 93.10M
March 31, 2025 92.20M
December 31, 2024 91.30M
September 30, 2024 91.00M
June 30, 2024 90.90M
March 31, 2024 90.50M
December 31, 2023 89.90M
September 30, 2023 82.10M
June 30, 2023 81.90M
March 31, 2023 81.50M
December 31, 2022 81.20M
September 30, 2022 80.90M
June 30, 2022 80.60M
March 31, 2022 80.30M
December 31, 2021 80.00M
September 30, 2021 79.70M
June 30, 2021 77.70M
March 31, 2021 76.70M
June 30, 2020 74.70M
March 31, 2020 74.50M
December 31, 2019 74.50M
Date Value
September 30, 2019 74.40M
June 30, 2019 73.50M
March 31, 2019 73.40M
December 31, 2018 73.20M
September 30, 2018 74.70M
June 30, 2018 70.60M
March 31, 2018 69.90M
December 31, 2017 69.40M
September 30, 2017 69.20M
June 30, 2017 68.40M
March 31, 2017 68.10M
December 31, 2016 68.10M
September 30, 2016 68.40M
June 30, 2016 69.10M
March 31, 2016 70.40M
December 31, 2015 71.60M
September 30, 2015 69.40M
June 30, 2015 68.90M
March 31, 2015 70.02M
December 31, 2014 71.52M
September 30, 2014 72.98M
June 30, 2014 73.50M
March 31, 2014 74.51M
December 31, 2013 73.97M
September 30, 2013 76.82M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Natera, Inc. 143.61M
Sera Prognostics, Inc. 39.44M
BioRestorative Therapies, Inc. 1.274M
CareDx, Inc. 51.48M
Exagen, Inc. 24.19M